Baxter Bros Inc’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Baxter Bros Inc’s Portfolio VRX Stock Details VRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,900	Closed	-$370K	–	117
2018 Q2	$370K	Sell	15,900 -4,000	-20%	-$93.1K	0.1%	93
2018 Q1	$317K	Hold	19,900	–	–	0.09%	98
2017 Q4	$414K	Sell	19,900 -8,900	-31%	-$185K	0.11%	91
2017 Q3	$413K	Sell	28,800 -2,700	-9%	-$38.7K	0.12%	88
2017 Q2	$545K	Buy	31,500 +875	+3%	+$15.1K	0.16%	79
2017 Q1	$338K	Buy	+30,625	New	+$338K	0.11%	92

Baxter Bros Inc's VRX Position: Q3 2018 in Review

Baxter Bros Inc sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q3 2018, closing a stake of 15,900 shares — an estimated $370K sold.

Baxter Bros Inc first reported a position in VRX in Q1 2017 and held it in 6 quarters. The position peaked at $545K in Q2 2017. 0 funds tracked by Wall St. Rank hold VRX as of Q3 2018.

Baxter Bros Inc reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q3 2018 after selling out during the quarter.
Baxter Bros Inc sold 15,900 VALEANT PHARMACEUTICALS INTL shares in Q3 2018, an estimated $370K.
Baxter Bros Inc first reported a position in VALEANT PHARMACEUTICALS INTL in Q1 2017 and held it in 6 quarters.
Baxter Bros Inc's VALEANT PHARMACEUTICALS INTL position peaked at $545K in Q2 2017.
0 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q3 2018.

Based on Baxter Bros Inc's 13F filing for Q3 2018, filed 11 Oct 2018.